Afinum and SHS Capital have sold their stakes in Switzerland-based diagnostic and therapeutic antibodies specialist Evitria toSweden-based Atlas Antibodies in a deal that values Evitria atmore than EUR 200m.

Atlas Antibodies acquires evitria Atlas Antibodies has agreed to acquire evitria, a world leader in transient recombinant antibody expression in CHO cells. This transformative acquisition brings together a leading provider of highly validated research antibodies and a front-runner in the field of custom recombinant antibody expression. Since its inception in 2010, evitria has been singularly […]

An interview with Dr Hanno Kühn, Chief Investment Officer (CIO) and head of apoBank’s institutional investment business, and Hubertus Leonhardt, Managing Director and partner of SHS Gesellschaft für Beteiligungsmanagement mbH. Düsseldorf and Tübingen , 22.7.2021 As the largest cooperative primary bank in Germany, apoBank is the number one financial services provider in the health care […]

An interview with Dr Hanno Kühn, Chief Investment Officer (CIO) and head of apoBank’s institutional investment business, and Hubertus Leonhardt, Managing Director and partner of SHS Gesellschaft für Beteiligungsmanagement mbH. As the largest cooperative primary bank in Germany, apoBank is the number one financial services provider in the health care sector. Its business activities include […]

Artificial intelligence will revolutionise the healthcare sector in this decade. With smart concepts and innovative healthtech products, we can make the healthcare system more efficient and effective.

The Tübingen-based healthcare investor SHS has accompanied Crystal GmbH on its growth path with its know-how, the required capital and extensive networks. Crystal’s optical components are used, for example, in the medical technology industry in respirators and as diffusion-bonded laser crystals in the manufacture of laser systems. The new investor Silver Investment Partners (SIP) will […]

For the future performance and efficiency in medical care, the degree of digitalisation will be decisive, in addition to the qualified specialist staff.

Incision is rapidly expanding its platform for surgical performance and online training The German SHS Gesellschaft für Beteiligungsmanagement mbH and investor Rubio Impact Ventures from Amsterdam provide 5 million euros for the expansion of Incision Group’s international business Operating room staff and surgical residents from over 200 hospitals in more than 18 countries now use […]

Corona hits everyone, including the healthcare industry – which is essential to a functioning healthcare system.

ntv reported in an exciting TV report about Mental Health Apps with focus on the DiGa of the SHS portfolio company Selfapy GmbH. It shows that digital therapies are increasingly arriving in mainstream care. Especially in the pandemic, low-threshold digital solutions are a great added value for patients.

Despite the Corona pandemic, the high-tech company Tyromotion GmbH reports considerable success. Tyromotion develops state-of-the-art rehabilitation devices, among others for MS patients and stroke patients. Thanks to state-of-the-art robotics, sensor technology and virtual reality, the rehabilitation process becomes more intensive and the patient sees successes more quickly. The concept also convinced customers in Australia, where […]

Neuro Event Labs Oy is a leading healthtech company in the field of AI-based diagnosis and monitoring of epilepsy patients. Now the SHS portfolio company announces an extensive cooperation with Filadelfia Epilepsy Hospital in Dianalund. The renowned specialist clinic for epilepsy patients in western Denmark will use the AI-based diagnostic tool Nelli Pro on all […]